Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion

Guolong Yu, Lin Xu, Martin Hadman, David C Hess, Cesar V. Borlongan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Recent laboratory and clinical studies demonstrate therapeutic efficacy of intracerebral transplantation of carotid body (CB) in Parkinson's disease, possibly through secretion of neurotrophic factors. Here, we examined the role of CB in experimental stroke. In the first experiment, we hypothesized that removal of CB would exacerbate cerebral infarction and stroke-related behavioral deficits. Eight-week-old, male Sprague-Dawley rats were randomly divided into two groups: stroke with intact CB and stroke with surgically removed CB. We used the stroke model of temporary middle cerebral artery occlusion. The ipsilateral CB was removed in animals assigned to treatment group exposed to stroke with surgically removed CB. Behavioral tests, using the elevated body swing test, were conducted at days 1-3 after surgery. Cerebral infarction was visualized by TTC staining on day 3 post-surgery. The data revealed no significant differences in behavioral deficits and infarct volumes between the two groups. In the second experiment, CB cell suspension grafts or control adult tissue grafts were intracerebally transplanted into the ischemic penumbra immediately (within 1 h) after stroke surgery. The results revealed significant reduction of behavioral deficits and infarct volumes, accompanied by increased levels of neurotrophic factors, as detected by ELISA, in transplanted ischemic striatum collected from CB-grafted stroke animals. These observations suggest that surgical resection of CB in the periphery did not alter stroke pathology; however, CB when made available in the CNS, via intracerebral transplantation, could protect against stroke possibly through the synergistic release of neurotrophic factors. The present study extends the use of CB as efficacious graft source for transplantation.

Original languageEnglish (US)
Pages (from-to)50-56
Number of pages7
JournalBrain Research
Volume1015
Issue number1-2
DOIs
StatePublished - Jul 23 2004

Fingerprint

Carotid Body
Middle Cerebral Artery Infarction
Transplantation
Stroke
Nerve Growth Factors
Cerebral Infarction
Transplants
Sprague Dawley Rats
Parkinson Disease
Suspensions

Keywords

  • Carotid body
  • Cerebral ischemia
  • Development and regeneration
  • Infarct volume
  • Middle cerebral artery occlusion
  • Neurotrophic factor
  • Transplantation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion. / Yu, Guolong; Xu, Lin; Hadman, Martin; Hess, David C; Borlongan, Cesar V.

In: Brain Research, Vol. 1015, No. 1-2, 23.07.2004, p. 50-56.

Research output: Contribution to journalArticle

Yu, Guolong ; Xu, Lin ; Hadman, Martin ; Hess, David C ; Borlongan, Cesar V. / Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion. In: Brain Research. 2004 ; Vol. 1015, No. 1-2. pp. 50-56.
@article{e65c52607444420b93e84bdb037d5996,
title = "Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion",
abstract = "Recent laboratory and clinical studies demonstrate therapeutic efficacy of intracerebral transplantation of carotid body (CB) in Parkinson's disease, possibly through secretion of neurotrophic factors. Here, we examined the role of CB in experimental stroke. In the first experiment, we hypothesized that removal of CB would exacerbate cerebral infarction and stroke-related behavioral deficits. Eight-week-old, male Sprague-Dawley rats were randomly divided into two groups: stroke with intact CB and stroke with surgically removed CB. We used the stroke model of temporary middle cerebral artery occlusion. The ipsilateral CB was removed in animals assigned to treatment group exposed to stroke with surgically removed CB. Behavioral tests, using the elevated body swing test, were conducted at days 1-3 after surgery. Cerebral infarction was visualized by TTC staining on day 3 post-surgery. The data revealed no significant differences in behavioral deficits and infarct volumes between the two groups. In the second experiment, CB cell suspension grafts or control adult tissue grafts were intracerebally transplanted into the ischemic penumbra immediately (within 1 h) after stroke surgery. The results revealed significant reduction of behavioral deficits and infarct volumes, accompanied by increased levels of neurotrophic factors, as detected by ELISA, in transplanted ischemic striatum collected from CB-grafted stroke animals. These observations suggest that surgical resection of CB in the periphery did not alter stroke pathology; however, CB when made available in the CNS, via intracerebral transplantation, could protect against stroke possibly through the synergistic release of neurotrophic factors. The present study extends the use of CB as efficacious graft source for transplantation.",
keywords = "Carotid body, Cerebral ischemia, Development and regeneration, Infarct volume, Middle cerebral artery occlusion, Neurotrophic factor, Transplantation",
author = "Guolong Yu and Lin Xu and Martin Hadman and Hess, {David C} and Borlongan, {Cesar V.}",
year = "2004",
month = "7",
day = "23",
doi = "10.1016/j.brainres.2004.04.055",
language = "English (US)",
volume = "1015",
pages = "50--56",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion

AU - Yu, Guolong

AU - Xu, Lin

AU - Hadman, Martin

AU - Hess, David C

AU - Borlongan, Cesar V.

PY - 2004/7/23

Y1 - 2004/7/23

N2 - Recent laboratory and clinical studies demonstrate therapeutic efficacy of intracerebral transplantation of carotid body (CB) in Parkinson's disease, possibly through secretion of neurotrophic factors. Here, we examined the role of CB in experimental stroke. In the first experiment, we hypothesized that removal of CB would exacerbate cerebral infarction and stroke-related behavioral deficits. Eight-week-old, male Sprague-Dawley rats were randomly divided into two groups: stroke with intact CB and stroke with surgically removed CB. We used the stroke model of temporary middle cerebral artery occlusion. The ipsilateral CB was removed in animals assigned to treatment group exposed to stroke with surgically removed CB. Behavioral tests, using the elevated body swing test, were conducted at days 1-3 after surgery. Cerebral infarction was visualized by TTC staining on day 3 post-surgery. The data revealed no significant differences in behavioral deficits and infarct volumes between the two groups. In the second experiment, CB cell suspension grafts or control adult tissue grafts were intracerebally transplanted into the ischemic penumbra immediately (within 1 h) after stroke surgery. The results revealed significant reduction of behavioral deficits and infarct volumes, accompanied by increased levels of neurotrophic factors, as detected by ELISA, in transplanted ischemic striatum collected from CB-grafted stroke animals. These observations suggest that surgical resection of CB in the periphery did not alter stroke pathology; however, CB when made available in the CNS, via intracerebral transplantation, could protect against stroke possibly through the synergistic release of neurotrophic factors. The present study extends the use of CB as efficacious graft source for transplantation.

AB - Recent laboratory and clinical studies demonstrate therapeutic efficacy of intracerebral transplantation of carotid body (CB) in Parkinson's disease, possibly through secretion of neurotrophic factors. Here, we examined the role of CB in experimental stroke. In the first experiment, we hypothesized that removal of CB would exacerbate cerebral infarction and stroke-related behavioral deficits. Eight-week-old, male Sprague-Dawley rats were randomly divided into two groups: stroke with intact CB and stroke with surgically removed CB. We used the stroke model of temporary middle cerebral artery occlusion. The ipsilateral CB was removed in animals assigned to treatment group exposed to stroke with surgically removed CB. Behavioral tests, using the elevated body swing test, were conducted at days 1-3 after surgery. Cerebral infarction was visualized by TTC staining on day 3 post-surgery. The data revealed no significant differences in behavioral deficits and infarct volumes between the two groups. In the second experiment, CB cell suspension grafts or control adult tissue grafts were intracerebally transplanted into the ischemic penumbra immediately (within 1 h) after stroke surgery. The results revealed significant reduction of behavioral deficits and infarct volumes, accompanied by increased levels of neurotrophic factors, as detected by ELISA, in transplanted ischemic striatum collected from CB-grafted stroke animals. These observations suggest that surgical resection of CB in the periphery did not alter stroke pathology; however, CB when made available in the CNS, via intracerebral transplantation, could protect against stroke possibly through the synergistic release of neurotrophic factors. The present study extends the use of CB as efficacious graft source for transplantation.

KW - Carotid body

KW - Cerebral ischemia

KW - Development and regeneration

KW - Infarct volume

KW - Middle cerebral artery occlusion

KW - Neurotrophic factor

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=3042604798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042604798&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2004.04.055

DO - 10.1016/j.brainres.2004.04.055

M3 - Article

C2 - 15223366

AN - SCOPUS:3042604798

VL - 1015

SP - 50

EP - 56

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -